Ginsenoside fractions regulate the action of monocytes and their differentiation into dendritic cells

Journal of Ginseng Research

Volumn 39, Issue 1, 2015, Pages 29-37

  Lee, Yeo Jin ^a   Son, Young Min ^a   Gu, Min Jeong ^a   Song, Ki Duk ^a,b   Park, Sung Moo ^a,b   Song, Hyo Jin ^a   Kang, Jae Sung ^a   Woo, Jong Soo ^a   Jung, Jee Hyung ^c   Yang, Deok Chun ^d   Han, Seung Hyun ^a   Yun, Cheol Heui ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University   (South Korea)

^c Pusan National University   (South Korea)

^d Kyung Hee University   (South Korea)

Author keywords

CD14+ monocytes; CD4+ T cells; Dendritic cells; Ginsenosides; Panax ginseng

Indexed keywords

CD14 ANTIGEN; GINSENOSIDE; GINSENOSIDE RB 1; GINSENOSIDE RB 2; GINSENOSIDE RC; GINSENOSIDE RD; GINSENOSIDE RE; GINSENOSIDE RG 1; GINSENOSIDE RG 3; GINSENOSIDE RH 2; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG ISOLATION; GINSENG; HUMAN; HUMAN CELL; IMMUNOMODULATION; MONOCYTE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

PANAX GINSENG;

EID: 84961290797     PISSN: 12268453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgr.2014.07.003     Document Type: Article

References (26)

1. Kiefer D, Pantuso T. Panax ginseng. Am Fam Physician 2003; 68:1539-42.
2. Lee TK, Johnke RM, Allison RR, O’Brien KF, Dobbs Jr LJ. Radioprotective potential of ginseng. Mutagenesis 2005; 20:237-43.
3. Kang KA, Kang JH, Yang MP. Ginseng total saponin enhances the phagocytic capacity of canine peripheral blood phagocytes in vitro. Am J Chin Med 2008; 36:329-41.
4. Fan ZH, Isobe K, Kiuchi K, Nakashima I. Enhancement of nitric oxide production from activated macrophages by a purified form of ginsenoside (Rg1). Am J Chin Med 1995; 23:279-87.
5. Park EK, Choo MK, Han MJ, Kim DH. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int Arch Allergy Immunol 2004; 133:113-20.
6. Whitelaw DM. Observations on human mono cyte kinetics after pulse labeling. Cell Tissue Kinet 1972; 5:311-7.
7. van Furth R, Cohn ZA. The origin and kinetics of mononuclear phagocytes. J Exp Med 1968; 128:415-35.
8. Xu H, Kramer M, Spengler HP, Peters JH. Dendritic cells differentiated from human monocytes through a combination of IL-4, GM-CSF and IFN-gamma exhibit phenotype and function of blood dendritic cells. Adv Exp Med Biol 1995; 378:75-8.
9. + peripheral blood monocytes. J Immunol 1996; 157:3850-9.
10. Tung NH, Quang TH, Son JH, Koo JE, Hong HJ, Koh YS, Song GY, Kim YH. Inhibitory effect of ginsenosides from steamed ginseng-leaves and flowers on the LPS-stimulated IL-12 production in bone marrow-derived dendritic cells. Arch Pharm Res 2011; 34:681-5.
11. Cheng LQ, Na JR, Bang MH, Kim MK, Yang DC. Conversion of major ginsenoside Rb1 to 20(S)-ginsenoside Rg3 by Microbacterium sp. GS514. Phytochemistry 2008; 69:218-24.
12. Son YM, Ahn SM, Jang MS, Moon YS, Kim SH, Cho KK, Han SH, Yun CH. Immunomodulatory effect of resistin in human dendritic cells stimulated with lipoteichoic acid from Staphylococcus aureus. Biochem Biophys Res Commun 2008; 376:599-604.
13. Jacobs DM, Morrison DC. Inhibition of the mitogenic response to lipopolysaccharide (LPS) in mouse spleen cells by polymyxin B. J Immunol 1977; 118: 21-7.
14. de Saint-Vis B, Vincent J, Vandenabeele S, Vanbervliet B, Pin JJ, Ait-Yahia S, Patel S, Mattei MG, Banchereau J, Zurawski S, et al. A novel lysosomeassociated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity 1998; 9: 325-36.
15. Molnar-Kimber KL, Yonno L, Heaslip RJ, Weichman BM. Differential regulation of TNF-alpha and IL-1beta production from endotoxin stimulated human monocytes by phosphodiesterase inhibitors. Mediators Inflamm 1992; 1: 411-7.
16. Lau WS, Chen WF, Chan RY, Guo DA, Wong MS. Mitogen-activated protein kinase (MAPK) pathway mediates the oestrogen-like activities of ginsenoside Rg1 in human breast cancer (MCF-7) cells. Br J Pharmacol 2009; 156:1136-46.
17. Lee IK, Kang KA, Lim CM, Kim KC, Kim HS, Kim DH, Kim BJ, Chang WY, Choi JH, Hyun JW. Compound K, a metabolite of ginseng aaponin, induces mitochondria- dependent and caspase-dependent apoptosis via the generation of reactive oxygen species in human colon cancer cells. Int J Mol Sci 2010; 11: 4916-31.
18. Wang Y, Wang BX, Liu TH, Minami M, Nagata T, Ikejima T. Metabolism of ginsenoside Rg1 by intestinal bacteria. II. Immunological activity of ginsenoside Rg1 and Rh1. Acta Pharmacol Sin 2000; 21:792-6.
19. Choi YJ, Yoon JH, Cha SW, Lee SG. Ginsenoside Rh1 inhibits the invasion and migration of THP-1 acute monocytic leukemia cells via inactivation of the MAPK signaling pathway. Fitoterapia 2011; 82:911-9.
20. Bae EA, Kim EJ, Park JS, Kim HS, Ryu JH, Kim DH. Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/ interferon-gamma-stimulated BV-2 microglial cells. Planta Med 2006; 72:627-33.
21. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: Multiple constituents and multiple actions. Biochem Pharmacol 1999; 58:1685-93.
22. Wheat WH, Pauken KE, Morris RV, Titus RG. Lutzomyia longipalpis salivary peptide maxadilan alters murine dendritic cell expression of CD80/86, CCR7, and cytokine secretion and reprograms dendritic cell-mediated cytokine release from cultures containing allogeneic T cells. J Immunol 2008; 180: 8286-98.
23. Cavassani KA, Aliberti JC, Dias AR, Silva JS, Ferreira BR. Tick saliva inhibits differentiation, maturation and function of murine bone-marrow-derived dendritic cells. Immunology 2005; 114:235-45.
24. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003; 21:685-711.
25. Boks MA, Kager-Groenland JR, Haasjes MS, Zwaginga JJ, van Ham SM, ten Brinke A. IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell inductionea comparative study of human clinicalapplicable DC. Clin Immunol 2012; 142:332-42.
26. Wolfle SJ, Strebovsky J, Bartz H, Sahr A, Arnold C, Kaiser C, Dalpke AH, Heeg K. PD-L1 expression on tolerogenic APCs is controlled by STAT-3. Eur J Immunol 2011; 41:413-24.